• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivanza Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4834.0
  • ISIN : INE984E01035
2.08 0 (4.52%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1.90

  • Today’s High

    2.08

  • Open

    1.99

  • Perv Close

    1.99

  • 52W Low

    1.90

  • 52W High

    9.54

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    8.32

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.24

  • Debt-Equity Ratio

    4.52

  • AGM Date

    01-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.51

  • Mar.Cap (₹Cr.)

    8.32

  • RONW (%)

    12.60

  • ROCE (%)

    10.23

Score Board

  • Equity (₹ in Cr.)

    4.00

  • BV (₹)

    1.20

  • Sales( ₹ in Cr.)

    14.41

  • NP (in Cr.)

    0.32

  • NP Var(%)

    -44.0

  • Div%

    0.0

  • CPS (₹)

    0.10

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    8.32

  • 52 Week High

    9.54

  • 52 Week Low

    1.90

  • Price BSE

    2.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    8.32

  • P/C Ratio

    24.30

  • P/E Ratio

    25.20

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 14.41 14.21 9.15 9.22 9.43 2.22
Excise Duty 14.41 13.56 9.15 9.22 9.43 2.22
Net Sales 14.41 14.21 9.15 9.22 9.43 2.22
Other Income 0.05 0.39 0.83 0.50 0.53 0.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 14.47 14.59 9.98 9.72 9.96 2.22
EXPENDITURE :
Raw Materials 14.41 13.56 9.15 9.22 9.43 2.22
Power & Fuel Cost 14.41 13.56 9.15 9.22 9.43 2.22
Employee Cost 0.31 0.26 0.12 0.29 0.26 0.11
Other Manufacturing Expenses 0.06 0.10 0.19 0.07 0.06 0.01
Selling & Administrative Expenses 0.26 0.17 0.30 0.17 0.26 0.15
Miscellaneous Expenses 0.06 0.10 0.19 0.07 0.06 0.01
Less : Pre-operative Expenses Capitalised :
Total Expenditure 14.04 13.91 9.51 9.57 10.17 2.67
Operating Profit 0.00 0.00 0.00 0.00 0.02 0.00
Interest 0.41 0.42 0.41 0.47 0.44 0.42
Gross Profit 0.43 0.69 0.46 0.15 -0.20 -0.45
Depreciation 0.01 0.00 0.01 0.01 0.00 0.00
Profit Before Tax 0.43 0.69 0.46 0.15 -0.20 -0.45
Tax 0.11 0.12 0.00 0.05 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.32 0.57 0.46 0.10 -0.20 -0.45
Extraordinary Items 0.43 0.69 0.46 0.15 -0.20 -0.45
Adjusted Net Profit 0.32 0.57 0.46 0.10 -0.20 -0.45
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.32 0.57 0.46 0.10 -0.20 -0.45
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.08 1.42 1.16 0.25 -0.51 -1.12
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    20.02%

  • Public Share Holding

    79.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,007,833 20.02 8,007,833 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,007,833 20.02 8,007,833 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 200 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 600 0.00 200 2
2] Non Institution
Bodies Corporate 1,610,056 4.03 1,606,506 21
Clearing Members 10,800 0.03 10,800 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 329,795 0.82 324,695 55
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,543,013 3.86 1,543,013 75
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,223,399 8.06 3,223,399 9
Individuals holding nominal share capital up to Rs. 1 lakh 25,261,992 63.16 23,747,302 20,463
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 12,000 0.03 12,000 3
Sub Total 31,991,567 79.98 30,468,227 20,631
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 40,000,000 100.00 38,476,260 20,635

Company Background

Vivanza Biosciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivanza Biosciences Ltd
  • BSE Code : 4834.0
  • ISIN : INE984E01035

  • Incorporation Year

    1982

  • Registered Office

    403 Sarthik 2 Opp Rajpath Club
    S G Highway, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-07405699869

  • FAX

  • Chairman

  • Managing Director

    Jayendra Mehta

  • Company Secretary

  • Auditor

    Shivam Soni & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Vivanza Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivanza Biosci. 2.08 14.47 14.41 -69.33 8.98
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92